US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

62.90

+0.66001.06%

Post-market: 64.001.10+1.75%17:13 EDT

Volume:1.20M

Turnover:75.26M

Market Cap:6.64B

PE:51.14

High:64.26

Open:62.06

Low:61.75

Close:62.24

Loading ...

Overview Company News Filings

BRIEF-Diabetes Care Publishes Results From Prevalence Phase Of Corcept’S CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes

Diabetes Care Publishes Results From Prevalence Phase of Corcept’s Catalyst Trial in People With Difficult-to-Control Type 2 Diabetes

THOMSON REUTERS

Analysts’ Top Healthcare Picks: Merus (MRUS), Corcept Therapeutics (CORT)

Corcept Therapeutics (NasdaqCM:CORT) Rises 36% in Last Quarter

Simply Wall St.

BRIEF-Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And Bevacizumab

Corcept Therapeutics Inc - Bella Trial to Enroll 90 Women With Platinum-Resistant Ovarian Cancer

THOMSON REUTERS

Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer

Corcept Therapeutics Is Maintained at Overweight by Piper Sandler

Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

Why Corcept Therapeutics Incorporated (CORT) Went Up On Monday?

Canaccord Genuity Sticks to Its Buy Rating for Corcept Therapeutics (CORT)

Corcept Therapeutics Inc : Piper Sandler Raises Target Price to $128 From $78

THOMSON REUTERS

Small U.S. Stocks End Mixed As Corcept Therapeutics Lead, LZ Technology Holdings Lags

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CORT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CORT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORT\",,,,,undefined,":{"symbol":"CORT","market":"US","secType":"STK","nameCN":"Corcept Therapeutics","latestPrice":62.9,"timestamp":1745265600000,"preClose":62.24,"halted":0,"volume":1197859,"hourTrading":{"tag":"盘后","latestPrice":64,"preClose":62.9,"latestTime":"17:13 EDT","volume":7592,"amount":477547.929872,"timestamp":1745269990745},"delay":0,"floatShares":86953354,"shares":105503432,"eps":1.23,"marketStatus":"Post-Mkt","change":0.66,"latestTime":"04-21 18:23:55 EDT","open":62.06,"high":64.26,"low":61.75,"amount":75256530.21875301,"amplitude":0.040328,"askPrice":64,"askSize":30,"bidPrice":61,"bidSize":25,"shortable":3,"etf":0,"ttmEps":1.23,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1081915200000,"exchange":"NASDAQ","adjPreClose":62.24,"preHourTrading":{"tag":"盘前","latestPrice":61.94,"preClose":62.24,"latestTime":"09:27 EDT","volume":573,"amount":35906.23707,"timestamp":1745242070109},"postHourTrading":{"tag":"盘后","latestPrice":64,"preClose":62.9,"latestTime":"17:13 EDT","volume":7592,"amount":477547.929872,"timestamp":1745269990745},"volumeRatio":0.903701,"impliedVol":0.7375,"impliedVolPercentile":0.68},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORT\",,,,,undefined,":{"symbol":"CORT","floatShares":86953354,"roa":"11.71%","roe":"23.81%","lyrEps":1.353582,"volumeRatio":0.903701,"shares":105503432,"dividePrice":0,"high":64.26,"amplitude":0.040328,"preClose":62.24,"low":61.75,"week52Low":20.84,"pbRate":"9.76","psRate":"9.83","week52High":117.33,"institutionHeld":0.7266,"latestPrice":62.9,"committee":-0.090909,"eps":1.23,"divideRate":0,"volume":1197859,"delay":0,"ttmEps":1.23,"open":62.06,"prevYearClose":50.39,"prevWeekClose":62.24,"prevMonthClose":114.22,"prevQuarterClose":114.22,"fiveDayClose":68.62,"twentyDayClose":58.66,"sixtyDayClose":62.29},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CORT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529034158","title":"BRIEF-Diabetes Care Publishes Results From Prevalence Phase Of Corcept’S CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2529034158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529034158?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:17","pubTimestamp":1745237829,"startTime":"0","endTime":"0","summary":"BRIEF-Diabetes Care Publishes Results From Prevalence Phase Of Corcept’S CATALYST Trial In People With Difficult-To-Control Type 2 DiabetesApril 21 (Reuters) - Corcept Therapeutics Inc CORT.O:DIABETES","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8TTPSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CORT","LU0566484027.USD","BK4532","LU1559883803.SGD"],"gpt_icon":1},{"id":"2529651808","title":"Diabetes Care Publishes Results From Prevalence Phase of Corcept’s Catalyst Trial in People With Difficult-to-Control Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2529651808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529651808?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:00","pubTimestamp":1745236803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8TTPSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0566484027.USD","BK4532","CORT","LU1559883803.SGD"],"gpt_icon":0},{"id":"2528719732","title":"Analysts’ Top Healthcare Picks: Merus (MRUS), Corcept Therapeutics (CORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528719732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528719732?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:13","pubTimestamp":1744892010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merus (MRUS – Research Report) and Corcept Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-merus-mrus-corcept-therapeutics-cort?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-merus-mrus-corcept-therapeutics-cort?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","HCSG","BK4532","MRUS","LU1559883803.SGD","BK4139","LU0566484027.USD","LU0320765992.SGD","CORT","BK4007","BK4137","LU0109394709.USD"],"gpt_icon":0},{"id":"2526317979","title":"Corcept Therapeutics (NasdaqCM:CORT) Rises 36% in Last Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2526317979","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526317979?lang=en_us&edition=fundamental","pubTime":"2025-04-10 03:02","pubTimestamp":1744225337,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics saw a remarkable 36% increase in its share price in the last quarter, driven by several key developments. The company's significant announcement on March 31, detailing the successful Phase 3 trial results of the ROSELLA study, likely provided a strong boost to investor confidence, as it highlighted a 30% reduction in disease progression risk for its treatment in ovarian cancer. This positive momentum was further supported by the initiation of the BELLA and MOMENTUM trials, showcasing Corcept's continuous efforts in advancing its pipeline. These developments, against a backdrop of a challenging market environment that saw a 12% decline, underscore their potential significance for Corcept’s growth.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-therapeutics-nasdaqcm-cort-rises-190217885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1559883803.SGD","BK4007","CORT","LU0566484027.USD","BK4532"],"gpt_icon":0},{"id":"2525304875","title":"BRIEF-Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And Bevacizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2525304875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525304875?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:54","pubTimestamp":1744030446,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And BevacizumabApril 7 (Reuters) - Corcept Therapeutics Inc CORT.O:CORCEPT INITIATES TRIAL OF RELACORILANT PLUS NAB-PACLITAXEL AND BEV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA9TPGFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1559883803.SGD","LU0566484027.USD","BK4007","CORT"],"gpt_icon":0},{"id":"2525012030","title":"Corcept Therapeutics Inc - Bella Trial to Enroll 90 Women With Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525012030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525012030?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA9TPGFQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0566484027.USD","CORT","LU1559883803.SGD","BK4007","BK4532"],"gpt_icon":0},{"id":"2525704880","title":"Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525704880","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525704880?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., April 07, 2025----Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the start of BELLA, a Phase 2 trial of relacorilant plus nab-paclitaxel and bevacizumab evaluating efficacy and safety in patients with platinum-resistant ovarian cancer.BELLA is a single-arm, open-label trial with a planned enrollment of 90 women with recurrent, platinum-resistant ovarian cancer at approximately 50 sites in North America, Europe and Asia-Pacific. Patients will receive relacorilant in combination with nab-paclitaxel and bevacizumab.\"In our pivotal Phase 3 ROSELLA trial, treatment with relacorilant and nab-paclitaxel improved patients’ progression-free and overall survival, without increasing their side effect burden,\" said Bill Guyer, PharmD, Corcept’s Chief Development ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-initiates-trial-relacorilant-plus-120000565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CORT","BK4532","EC","BK4201","LU0566484027.USD","LU1559883803.SGD","BK4007"],"gpt_icon":0},{"id":"2524684252","title":"Corcept Therapeutics Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2524684252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524684252?lang=en_us&edition=fundamental","pubTime":"2025-04-03 21:04","pubTimestamp":1743685440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CORT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 09:04 ET (13:04 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"47103062d186ffca036e42216ddd23e9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"1180105685","title":"Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1180105685","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180105685?lang=en_us&edition=fundamental","pubTime":"2025-04-03 08:20","pubTimestamp":1743639626,"startTime":"0","endTime":"0","summary":"CORCEPT THERAPEUTICS INC's Officer Joseph Douglas Lyon conducted multiple transactions on March 31 and April 1, selling a total of 200,650 shares of common stock, including several instances of shares acquired through option exercises before sale. Intensive reduction by executives typically implies the current stock price may be overvalued, which is worth investors' attention.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2524449342","title":"Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2524449342","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524449342?lang=en_us&edition=fundamental","pubTime":"2025-04-03 03:00","pubTimestamp":1743620400,"startTime":"0","endTime":"0","summary":"It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of Corcept Therapeutics Incorporated CORT skyrocketed after a late-stage study met its primary goal. On the other hand, Axsome Therapeutics’ AXSM shares declined after announcing results from a study on major depressive disorder .Shares of Corcept Therapeutics Incorporated surged on March 31 after the company announced the success of the late-stage ROSELLA study.The phase III ROSELLA study evaluated its pipeline candidate, relacorilant, in combination with nab-paclitaxel for treating patients with platinum-resistant ovarian cancer.Axsome Therapeutics announced top-line data from the phase III PARADIGM study, which evaluated solriamfetol for the treatment of major depressive disorder  with and without severe excessive daytime sleepiness .Nonetheless, in the prespecified subgroup of patients with severe EDS, treatment with solriamfetol led to greater improvements in depres","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-cort-study-190000499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","IE00BSNM7G36.USD","CORT","IE00BJT1NW94.SGD","LU0096364046.USD","BK4097","IE00B2B36J28.USD","LU1670710661.SGD","LU0321505868.SGD","LU1868836591.USD","BK4505","LU1670710588.SGD","IE00BJJMRZ35.SGD","LU2125154778.USD","BMY","LU1093756325.SGD","LU1585245621.USD","LU0306806265.USD","AXSM","LU2360032135.SGD","LU1093756168.USD","PFS","BK4585","LU1291159041.SGD","LU0566484027.USD","LU1868836757.USD","LU2125154935.USD","LU0225284248.USD","LU1670711040.USD","BK4532","BK4556","LU1323610961.USD","BK4588","LU0306807586.USD","LU0456855351.SGD","LU1571399168.USD","LU2242652126.USD","LU1989771016.USD","OS","BLUE","LU0321505439.SGD","BK4007","LU1074936037.SGD","BK4578","LU1670711123.USD","LU0985481810.HKD","LU0882574055.USD","LU2242646821.SGD","EXEL","LU1718418525.SGD"],"gpt_icon":1},{"id":"2524109415","title":"Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524109415","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524109415?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:55","pubTimestamp":1743602109,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics  closed the last trading session at $91.93, gaining 64.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $118.25 indicates a 28.6% upside potential.The average comprises four short-term price targets ranging from a low of $78 to a high of $150, with a standard deviation of $30.42. While the lowest estimate indicates a decline of 15.2% from the current price level, the most optimistic estimate points to a 63.2% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.However, an impressive consensus price target is not the only factor that indicates a potential upside in CORT. This view is strengthened by the agreement among analysts that the company will report better earnings than what the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/does-corcept-cort-potential-rally-135509890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CORT","LU0566484027.USD","LU1559883803.SGD","BK4007","BK4532"],"gpt_icon":0},{"id":"2524581497","title":"APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag","url":"https://stock-news.laohu8.com/highlight/detail?id=2524581497","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524581497?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:11","pubTimestamp":1743599460,"startTime":"0","endTime":"0","summary":"A filing accepted under the regulatory body’s Priority Review pathway reduces the review period to six months from the standard 10 months. This status is awarded to marketing applications for medicines intended to treat serious conditions and that, if approved, would offer a substantial improvement in safety, effectiveness, prevention, or diagnosis of such conditions.A final decision from the FDA is expected on July 28, 2025.Please note that Empaveli is approved in the United States for the treatment of paroxysmal nocturnal hemoglobinuria . The drug is also approved in Europe under the brand name Aspaveli for the same indication.Year to date, shares of Apellis have plunged 28.9% against theindustry’s 2.4% growth.In the VALIANT study, Empaveli was overall well-tolerated with a consistent safety profile. Adverse events were mostly mild to moderate in severity.Novartis recently announced that the FDA has approved Fabhalta for a third indication, C3G, to reduce proteinuria.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apls-empaveli-snda-2-rare-131100793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVS","APLS","LU1093756325.SGD","LU1559883803.SGD","IE00BFTCPJ56.SGD","BK4505","BK4139","LU0211331839.USD","BK4585","IE0002141913.USD","BK4578","LU0208291251.USD","LU0566484027.USD","CORT","IE00BJJMRZ35.SGD","LU0070302665.USD","IE00B2B36J28.USD","BK4532","LU1093756168.USD","IE00B4R5TH58.HKD","BAYRY","IE00BJT1NW94.SGD","BK4007","IE0009355771.USD","BK4588","LU0320765489.SGD"],"gpt_icon":0},{"id":"2524128774","title":"CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128774","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128774?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:50","pubTimestamp":1743519000,"startTime":"0","endTime":"0","summary":"Shares of Corcept Therapeutics Incorporated CORT were up a staggering 109.1% on March 31 after the company announced data from the phase III ROSELLA study, which evaluated its pipeline candidate, relacorilant, in combination with nab-paclitaxel for treating patients with platinum-resistant ovarian cancer.The ROSELLA study met its primary endpoint of improved progression-free survival, as assessed by blinded independent central review .Per management, data from the ROSELLA study suggested that the combo of relacorilant plus nab-paclitaxel has the potential to become a new standard of care for patients with platinum-resistant ovarian cancer.Year to date, shares of Corcept have skyrocketed 126.7% against the industry’s decline of 1.9%.The phase III ROSELLA study evaluated relacorilant in combination with nab-paclitaxel for treating patients with recurrent, platinum-resistant ovarian cancer.Data from the same showed that treatment with relacorilant plus nab-paclitaxel reduced the risk of d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cort-shares-rise-relacorilant-combo-145000011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FOLD","LU2065169927.USD","LU2065171402.SGD","CORT","ANIP","CTMX","OS","BK4097","BK4532","LU2065170008.USD","LU2065171311.SGD","LU0566484027.USD","LU1559883803.SGD","BK4007","BK4139"],"gpt_icon":0},{"id":"2524811253","title":"Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2524811253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524811253?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:45","pubTimestamp":1743515100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CORT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 09:45 ET (13:45 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2524145956","title":"SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145956","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145956?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:44","pubTimestamp":1743515040,"startTime":"0","endTime":"0","summary":"SanofiSNY and partner,Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia  as the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors in the United States.Hemophilia A and B are rare, lifelong congenital bleeding disorders that impair the blood's ability to clot, causing excessive bleeding and spontaneous joint bleeds. These can lead to joint damage, chronic pain, which takes a significant toll on the patients’ quality of life.This FDA approval is based on positive data from the phase III ATLAS studies of Qfitlia, which showed clinically significant bleed protection, as measured by annualized bleeding rates , in hemophilia patients with or without inhibitors.Year to date, SNY stock has gained 15% compared with the industry’s 3.4% growth.Further analysis in the open-label extension study, under the ATL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sny-gets-fda-nod-first-134400996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BAYRY","BK4110","BK4007","BK4588","BK4139","BK4548","CORT","ALNY","BK4211","IE00BFXG1179.USD","ABR","SNY","LU0566484027.USD","UBCP","BK4585","BK4532","LU1559883803.SGD"],"gpt_icon":0},{"id":"2524917146","title":"AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2524917146","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524917146?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:31","pubTimestamp":1743514260,"startTime":"0","endTime":"0","summary":"AstraZenecaAZN announced that the FDA has approved its blockbuster drug, Imfinzi, for a bladder cancer indication in the United States.Imfinzi is approved in combination with gemcitabine and cisplatin as a neoadjuvant treatment for muscle-invasive bladder cancer , a type of bladder cancer that has spread into the muscle wall of the bladder. The regulatory filing for the drug was reviewed under the FDA’s Priority Review Pathway. This marks the first approval for Imfinzi for a bladder cancer indication.AstraZeneca’s Imfinzi, either as a monotherapy or in combination with chemotherapy, is presently approved for stage III non-small cell lung cancer, extensive-stage small cell lung cancer, locally advanced or metastatic biliary tract cancer and endometrial cancer that is mismatch repair deficient and in combination with Imjudo in unresectable hepatocellular carcinoma in some countries. The drug has also recently been approved for limited-stage small cell lung cancer in the United States and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazenecas-imfinzi-gets-fda-nod-133100339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CORT","BK4532","LU2462157665.USD","CHMP","BAYRY","LU2456880835.USD","LU1559883803.SGD","LU1829250122.USD","LU0109394709.USD","BK4007","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","LU0566484027.USD","DVAX","BK4585","LU0320765992.SGD","BK4588","BK4087","BK4568","AZN"],"gpt_icon":0},{"id":"2524926261","title":"Why Corcept Therapeutics Incorporated (CORT) Went Up On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524926261","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524926261?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:13","pubTimestamp":1743506034,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Firms Kick Off Trading Week Stronger. In this article, we are going to take a look at where Corcept Therapeutics Incorporated  stands against other firms that kicked off the trading week stronger.The stock market began the trading week on a mixed note as investors continued to digest President Donald Trump’s new tariff agenda, with all economies expecting to be hit by import taxes.Among all major indices, only the Nasdaq registered losses, down 0.14 percent. In contrast, the Dow Jones jumped by 1 percent while the S&P 500 grew by 0.55 percent.Despite the broader market downturn, 10 individual stocks stood their ground, finishing the day in the green amid a flurry of fresh corporate developments that boosted investor appetite.In this article, we named Monday’s top performers and detailed the reasons behind their gains.Corcept Therapeutics soared by 109.08 percent on Monday to end at $114.22 apiece as investors cheered impressive results of its phase 3 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-corcept-therapeutics-incorporated-cort-111354123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1559883803.SGD","BK4007","CORT","LU0566484027.USD","BK4532"],"gpt_icon":1},{"id":"2524619499","title":"Canaccord Genuity Sticks to Its Buy Rating for Corcept Therapeutics (CORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524619499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524619499?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:55","pubTimestamp":1743504946,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Edward Nash maintained a Buy rating on Corcept Therapeutics (CORT – Research Report) today and set a price target of $142...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-its-buy-rating-for-corcept-therapeutics-cort?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-its-buy-rating-for-corcept-therapeutics-cort?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CORT"],"gpt_icon":0},{"id":"2524613661","title":"Corcept Therapeutics Inc : Piper Sandler Raises Target Price to $128 From $78","url":"https://stock-news.laohu8.com/highlight/detail?id=2524613661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524613661?lang=en_us&edition=fundamental","pubTime":"2025-04-01 11:56","pubTimestamp":1743479760,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QE1AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU1559883803.SGD","LU0566484027.USD","CORT","BK4532"],"gpt_icon":0},{"id":"2524972693","title":"Small U.S. Stocks End Mixed As Corcept Therapeutics Lead, LZ Technology Holdings Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2524972693","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524972693?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:21","pubTimestamp":1743452460,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Monday, as the Russell 2000 Index declined 0.6%, while the S&P Small Cap 600 Index was up 0.4%.Among companies with a market value of $1 billion to $6.7 billion, LZ Technology Holdings Ltd. Cl B was the biggest laggard during the session, dropping 19%, followed by shares of Biohaven Ltd., which dropped 13%. Shares of Beam Therapeutics Inc. dropped 12%, BioLife Solutions Inc. shares plunged 12%, and Spyre Therapeutics Inc. tumbled 10%.Corcept Therapeutics Inc. was the best performer, surging 109%, followed by Mr. Cooper Group Inc., which surged 14%. Verra Mobility Corp. Cl A shares jumped 11%, Loar Holdings Inc. surged 7.1%, and shares of Kestra Medical Technologies Ltd. jumped 6.4%.Major U.S. stock indexes finished mixed Monday as the Nasdaq Composite Index declined 0.1%. Meanwhile, the S&P 500 Index gained 0.6%, and the Dow Jones Industrial Average increased 1.0%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0566484027.USD","BK4539","LZ","BK4123","BK4551","CORT","BK4532","LU1559883803.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-26","symbol":"CORT","fiscalQuarterEnding":"2024/12","expectedEps":0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":0.26},{"market":"US","date":"2024-10-30","symbol":"CORT","fiscalQuarterEnding":"2024/09","expectedEps":0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"post","actualEps":0.41},{"market":"US","date":"2024-07-29","symbol":"CORT","fiscalQuarterEnding":"2024/06","expectedEps":0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722225600000,"reportTimeType":"post","actualEps":0.32},{"market":"US","date":"2024-05-01","symbol":"CORT","fiscalQuarterEnding":"2024/03","expectedEps":0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"post","actualEps":0.25},{"market":"US","date":"2024-02-15","symbol":"CORT","fiscalQuarterEnding":"2023/12","expectedEps":0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707973200000,"reportTimeType":"post","actualEps":0.28}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1700107200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CORT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CORT","date":"2025-04-17","current":48.265491,"percent":0.978896,"low":12.617742,"twenty":20.286086,"median":24.779141,"eighty":29.454515,"high":85.338767,"avg":26.190148,"sd":7.915387,"marketCap":6815521707},"quantilePoints":[{"date":"2020-04-24","current":15.988097,"twenty":-29.662778,"median":10.039278,"eighty":18.080162,"marketCap":1505774949},{"date":"2020-05-01","current":14.845254,"twenty":-29.662778,"median":10.16729,"eighty":18.080162,"marketCap":1398140837},{"date":"2020-05-08","current":14.523657,"twenty":-29.662778,"median":10.246957,"eighty":18.080162,"marketCap":1539100938},{"date":"2020-05-15","current":15.20496,"twenty":-29.662778,"median":10.402606,"eighty":18.080162,"marketCap":1611300014},{"date":"2020-05-22","current":17.032583,"twenty":-29.662778,"median":10.509751,"eighty":18.080162,"marketCap":1804976901},{"date":"2020-05-29","current":16.372908,"twenty":-29.662778,"median":10.517599,"eighty":18.080162,"marketCap":1735069859},{"date":"2020-06-05","current":15.345546,"twenty":-29.662778,"median":10.570633,"eighty":18.080162,"marketCap":1626198236},{"date":"2020-06-12","current":15.788934,"twenty":-29.662778,"median":10.632312,"eighty":18.080162,"marketCap":1673184936},{"date":"2020-06-19","current":17.503007,"twenty":-29.662778,"median":10.674036,"eighty":18.080162,"marketCap":1854828643},{"date":"2020-06-26","current":18.005874,"twenty":-29.662778,"median":10.737672,"eighty":18.13832,"marketCap":1908118438},{"date":"2020-07-02","current":18.579034,"twenty":-29.662778,"median":10.816326,"eighty":18.1602,"marketCap":1968857343},{"date":"2020-07-10","current":17.838251,"twenty":-29.662778,"median":10.956625,"eighty":18.168521,"marketCap":1890355173},{"date":"2020-07-17","current":17.82203,"twenty":-29.662778,"median":11.143818,"eighty":18.168521,"marketCap":1888636147},{"date":"2020-07-24","current":17.421899,"twenty":-29.662778,"median":11.212718,"eighty":18.178004,"marketCap":1846233515},{"date":"2020-07-31","current":16.167436,"twenty":-29.662778,"median":11.288088,"eighty":18.178004,"marketCap":1713295534},{"date":"2020-08-07","current":14.116479,"twenty":-29.662778,"median":11.383285,"eighty":18.178004,"marketCap":1610873724},{"date":"2020-08-14","current":13.939263,"twenty":-29.662778,"median":11.447928,"eighty":18.178004,"marketCap":1590651134},{"date":"2020-08-21","current":13.078502,"twenty":-29.662778,"median":11.607146,"eighty":18.178004,"marketCap":1492427127},{"date":"2020-08-28","current":12.769641,"twenty":-29.662778,"median":11.77016,"eighty":18.178004,"marketCap":1457182042},{"date":"2020-09-04","current":20.232944,"twenty":-29.662778,"median":12.0681,"eighty":18.192931,"marketCap":2308841966},{"date":"2020-09-11","current":17.964586,"twenty":-29.662778,"median":12.313861,"eighty":18.22447,"marketCap":2049992817},{"date":"2020-09-18","current":18.217751,"twenty":-29.662778,"median":12.50872,"eighty":18.227697,"marketCap":2078882231},{"date":"2020-09-25","current":17.306357,"twenty":-29.662778,"median":12.690857,"eighty":18.227697,"marketCap":1974880341},{"date":"2020-10-02","current":17.134205,"twenty":-29.662778,"median":12.772759,"eighty":18.227697,"marketCap":1955235539},{"date":"2020-10-09","current":18.582309,"twenty":-29.662778,"median":12.948505,"eighty":18.242559,"marketCap":2120482987},{"date":"2020-10-16","current":18.227878,"twenty":-29.662778,"median":13.039541,"eighty":18.265281,"marketCap":2080037808},{"date":"2020-10-23","current":18.075979,"twenty":-29.662778,"median":13.12871,"eighty":18.265281,"marketCap":2062704159},{"date":"2020-10-30","current":16.992433,"twenty":-29.662778,"median":13.207771,"eighty":18.265281,"marketCap":1939057467},{"date":"2020-11-06","current":19.210299,"twenty":-29.662778,"median":13.384252,"eighty":18.317545,"marketCap":2101568249},{"date":"2020-11-13","current":19.210299,"twenty":-29.662778,"median":13.650021,"eighty":18.406303,"marketCap":2101568249},{"date":"2020-11-20","current":25.411965,"twenty":-29.662778,"median":13.746278,"eighty":18.477389,"marketCap":2780018143},{"date":"2020-11-27","current":24.413752,"twenty":-29.662778,"median":13.837384,"eighty":18.52368,"marketCap":2670815591},{"date":"2020-12-04","current":25.008432,"twenty":-29.662778,"median":13.946858,"eighty":18.566015,"marketCap":2735872430},{"date":"2020-12-11","current":26.888046,"twenty":-29.662778,"median":14.03291,"eighty":18.609219,"marketCap":2941498511},{"date":"2020-12-18","current":27.88626,"twenty":-29.662778,"median":14.128307,"eighty":18.66755,"marketCap":3050701063},{"date":"2020-12-24","current":28.873854,"twenty":-29.662778,"median":14.204207,"eighty":18.752824,"marketCap":3158741885},{"date":"2020-12-31","current":27.780067,"twenty":-29.662778,"median":14.259111,"eighty":18.823955,"marketCap":3039083770},{"date":"2021-01-08","current":28.852615,"twenty":-29.662778,"median":14.437044,"eighty":18.90799,"marketCap":3156418426},{"date":"2021-01-15","current":29.882687,"twenty":-29.662778,"median":14.544352,"eighty":19.043327,"marketCap":3269106165},{"date":"2021-01-22","current":29.797732,"twenty":-29.662778,"median":14.568513,"eighty":19.173242,"marketCap":3259812331},{"date":"2021-01-29","current":30.010118,"twenty":-29.662778,"median":14.642599,"eighty":19.220775,"marketCap":3283046917},{"date":"2021-02-05","current":31.231337,"twenty":-29.662778,"median":14.727532,"eighty":19.357645,"marketCap":3416645783},{"date":"2021-02-12","current":29.734017,"twenty":-29.662778,"median":14.762883,"eighty":19.474737,"marketCap":3252841956},{"date":"2021-02-19","current":28.608372,"twenty":-29.662778,"median":14.848087,"eighty":19.754982,"marketCap":3129698653},{"date":"2021-02-26","current":27.831125,"twenty":-29.662778,"median":14.9005,"eighty":19.989119,"marketCap":2950405376},{"date":"2021-03-05","current":27.167162,"twenty":-29.662778,"median":14.992635,"eighty":20.173345,"marketCap":2880017971},{"date":"2021-03-12","current":28.428692,"twenty":-29.662778,"median":15.028869,"eighty":20.32634,"marketCap":3013754040},{"date":"2021-03-19","current":28.351229,"twenty":-29.662778,"median":15.068378,"eighty":20.471695,"marketCap":3005542176},{"date":"2021-03-26","current":27.089699,"twenty":-29.662778,"median":15.130098,"eighty":20.550186,"marketCap":2871806107},{"date":"2021-04-01","current":27.034369,"twenty":-29.662778,"median":15.171294,"eighty":20.747868,"marketCap":2865940490},{"date":"2021-04-09","current":25.09781,"twenty":-29.662778,"median":15.211446,"eighty":20.923746,"marketCap":2660643893},{"date":"2021-04-16","current":25.191871,"twenty":-29.662778,"median":15.278755,"eighty":21.20428,"marketCap":2670615442},{"date":"2021-04-23","current":26.40353,"twenty":-29.662778,"median":15.369745,"eighty":21.53034,"marketCap":2799064608},{"date":"2021-04-30","current":25.072352,"twenty":-29.662778,"median":15.47411,"eighty":22.287951,"marketCap":2657945100},{"date":"2021-05-07","current":24.754882,"twenty":-29.662778,"median":15.518576,"eighty":24.294815,"marketCap":2460907601},{"date":"2021-05-14","current":24.9074,"twenty":-29.662778,"median":15.610839,"eighty":24.413752,"marketCap":2476069591},{"date":"2021-05-21","current":25.247633,"twenty":-29.662778,"median":15.638633,"eighty":24.698476,"marketCap":2509892491},{"date":"2021-05-28","current":25.341491,"twenty":-29.662778,"median":15.686181,"eighty":24.861995,"marketCap":2519222947},{"date":"2021-06-04","current":25.11858,"twenty":-29.564231,"median":15.705567,"eighty":24.993109,"marketCap":2497063115},{"date":"2021-06-11","current":25.259366,"twenty":-29.564231,"median":15.782208,"eighty":25.114426,"marketCap":2511058798},{"date":"2021-06-18","current":26.397386,"twenty":-29.564231,"median":15.836865,"eighty":25.18427,"marketCap":2624190570},{"date":"2021-06-25","current":26.678958,"twenty":-29.564231,"median":15.876709,"eighty":25.257019,"marketCap":2652181936},{"date":"2021-07-02","current":26.174475,"twenty":-29.564231,"median":15.929368,"eighty":25.341445,"marketCap":2602030738},{"date":"2021-07-09","current":25.857706,"twenty":-29.357281,"median":15.951149,"eighty":25.408891,"marketCap":2570540451},{"date":"2021-07-16","current":23.698987,"twenty":-28.953237,"median":15.97248,"eighty":25.421286,"marketCap":2355939978},{"date":"2021-07-23","current":23.804576,"twenty":-28.83498,"median":16.047822,"eighty":25.421286,"marketCap":2366436740},{"date":"2021-07-30","current":24.668273,"twenty":7.658953,"median":16.153301,"eighty":25.421286,"marketCap":2407796084},{"date":"2021-08-06","current":25.927222,"twenty":8.529565,"median":16.182777,"eighty":25.604292,"marketCap":2530678311},{"date":"2021-08-13","current":24.561381,"twenty":8.686335,"median":16.258487,"eighty":25.617005,"marketCap":2397362687},{"date":"2021-08-20","current":24.466366,"twenty":8.870861,"median":16.364258,"eighty":25.617005,"marketCap":2388088557},{"date":"2021-08-27","current":25.570915,"twenty":9.046769,"median":16.394537,"eighty":25.617005,"marketCap":2495900322},{"date":"2021-09-03","current":25.570915,"twenty":9.231188,"median":16.443465,"eighty":25.64695,"marketCap":2495900322},{"date":"2021-09-10","current":25.06021,"twenty":9.353202,"median":16.481052,"eighty":25.64695,"marketCap":2446051871},{"date":"2021-09-17","current":24.359474,"twenty":9.563882,"median":16.545079,"eighty":25.64695,"marketCap":2377655160},{"date":"2021-09-24","current":24.098183,"twenty":9.648271,"median":16.60001,"eighty":25.64695,"marketCap":2352151302},{"date":"2021-10-01","current":23.563723,"twenty":9.818742,"median":16.632453,"eighty":25.64695,"marketCap":2299984319},{"date":"2021-10-08","current":24.157567,"twenty":9.8781,"median":16.710363,"eighty":25.642787,"marketCap":2357947633},{"date":"2021-10-15","current":23.801261,"twenty":9.911585,"median":16.806324,"eighty":25.642787,"marketCap":2323169645},{"date":"2021-10-22","current":22.233513,"twenty":10.120373,"median":16.916725,"eighty":25.642787,"marketCap":2170146494},{"date":"2021-10-29","current":21.378378,"twenty":10.16729,"median":16.975967,"eighty":25.638625,"marketCap":2086679322},{"date":"2021-11-05","current":22.428163,"twenty":10.247766,"median":17.021769,"eighty":25.638625,"marketCap":2387545188},{"date":"2021-11-12","current":24.946122,"twenty":10.405229,"median":17.108284,"eighty":25.638625,"marketCap":2655589545},{"date":"2021-11-19","current":24.805122,"twenty":10.509751,"median":17.160274,"eighty":25.638625,"marketCap":2640579691},{"date":"2021-11-26","current":23.308355,"twenty":10.517646,"median":17.193019,"eighty":25.638625,"marketCap":2481244318},{"date":"2021-12-03","current":22.679279,"twenty":10.570633,"median":17.245845,"eighty":25.638625,"marketCap":2414277277},{"date":"2021-12-10","current":20.336513,"twenty":10.633993,"median":17.285339,"eighty":25.638625,"marketCap":2164882781},{"date":"2021-12-17","current":20.45582,"twenty":10.674216,"median":17.377243,"eighty":25.638625,"marketCap":2177583426},{"date":"2021-12-23","current":19.753147,"twenty":10.722066,"median":17.416987,"eighty":25.638625,"marketCap":2102781801},{"date":"2021-12-31","current":19.703391,"twenty":10.819468,"median":17.454342,"eighty":25.638625,"marketCap":2097485121},{"date":"2022-01-07","current":18.857539,"twenty":10.913816,"median":17.567549,"eighty":25.634462,"marketCap":2007441568},{"date":"2022-01-14","current":18.359978,"twenty":11.137655,"median":17.627876,"eighty":25.634462,"marketCap":1954474772},{"date":"2022-01-21","current":17.106126,"twenty":11.176492,"median":17.634297,"eighty":25.634462,"marketCap":1820998446},{"date":"2022-01-28","current":17.524077,"twenty":11.270479,"median":17.649,"eighty":25.634462,"marketCap":1865490555},{"date":"2022-02-04","current":19.315294,"twenty":11.365143,"median":17.759255,"eighty":25.634462,"marketCap":2056171020},{"date":"2022-02-11","current":19.892464,"twenty":11.408008,"median":17.831672,"eighty":25.634462,"marketCap":2117612504},{"date":"2022-02-18","current":21.227889,"twenty":11.568834,"median":17.864938,"eighty":25.634462,"marketCap":2388392248},{"date":"2022-02-25","current":21.331486,"twenty":11.631674,"median":17.906314,"eighty":25.634462,"marketCap":2400048110},{"date":"2022-03-04","current":22.292109,"twenty":11.795058,"median":17.930398,"eighty":25.634462,"marketCap":2508129747},{"date":"2022-03-11","current":22.904271,"twenty":12.28719,"median":17.972454,"eighty":25.634462,"marketCap":2577005300},{"date":"2022-03-18","current":23.516432,"twenty":12.475052,"median":18.005093,"eighty":25.634462,"marketCap":2645880853},{"date":"2022-03-25","current":22.574645,"twenty":12.627441,"median":18.031905,"eighty":25.634462,"marketCap":2539918464},{"date":"2022-04-01","current":22.273273,"twenty":12.74917,"median":18.063294,"eighty":25.634462,"marketCap":2506010499},{"date":"2022-04-08","current":23.412836,"twenty":12.847907,"median":18.095067,"eighty":25.634462,"marketCap":2634224990},{"date":"2022-04-14","current":23.064375,"twenty":13.008366,"median":18.12447,"eighty":25.634462,"marketCap":2595018906},{"date":"2022-04-22","current":21.020696,"twenty":13.07616,"median":18.16833,"eighty":25.634462,"marketCap":2365080522},{"date":"2022-04-29","current":20.312779,"twenty":13.138468,"median":18.203209,"eighty":25.634462,"marketCap":2285431391},{"date":"2022-05-06","current":18.239814,"twenty":13.303116,"median":18.227652,"eighty":25.634462,"marketCap":2040013747},{"date":"2022-05-13","current":17.992816,"twenty":13.407715,"median":18.227652,"eighty":25.634462,"marketCap":2012388561},{"date":"2022-05-20","current":19.398802,"twenty":13.706817,"median":18.242251,"eighty":25.634462,"marketCap":2169639620},{"date":"2022-05-27","current":19.949796,"twenty":13.79308,"median":18.271684,"eighty":25.634462,"marketCap":2231265036},{"date":"2022-06-03","current":20.291793,"twenty":13.889642,"median":18.339285,"eighty":25.634462,"marketCap":2269515293},{"date":"2022-06-10","current":20.339292,"twenty":13.973328,"median":18.40556,"eighty":25.634462,"marketCap":2274827829},{"date":"2022-06-17","current":19.664799,"twenty":14.068138,"median":18.465203,"eighty":25.634462,"marketCap":2199389821},{"date":"2022-06-24","current":22.609769,"twenty":14.163827,"median":18.496311,"eighty":25.638625,"marketCap":2528767040},{"date":"2022-07-01","current":24.167753,"twenty":14.242503,"median":18.547204,"eighty":25.638625,"marketCap":2703018215},{"date":"2022-07-08","current":26.257732,"twenty":14.375881,"median":18.575405,"eighty":25.689659,"marketCap":2936769790},{"date":"2022-07-15","current":25.877736,"twenty":14.535395,"median":18.611477,"eighty":25.706312,"marketCap":2894269503},{"date":"2022-07-22","current":25.564239,"twenty":14.560417,"median":18.668127,"eighty":25.758082,"marketCap":2859206767},{"date":"2022-07-29","current":27.226722,"twenty":14.617956,"median":18.734208,"eighty":25.807402,"marketCap":3045145520},{"date":"2022-08-05","current":27.267222,"twenty":14.673898,"median":18.765235,"eighty":25.816914,"marketCap":3073915738},{"date":"2022-08-12","current":26.9917,"twenty":14.673898,"median":18.765235,"eighty":25.816914,"marketCap":3042855265},{"date":"2022-08-19","current":26.288642,"twenty":14.673898,"median":18.765235,"eighty":25.807402,"marketCap":2963597508},{"date":"2022-08-26","current":25.386069,"twenty":14.673898,"median":18.765235,"eighty":25.764749,"marketCap":2861847684},{"date":"2022-09-02","current":24.350484,"twenty":14.673898,"median":18.765235,"eighty":25.706312,"marketCap":2745103149},{"date":"2022-09-09","current":24.692512,"twenty":14.673898,"median":18.765235,"eighty":25.655304,"marketCap":2783660977},{"date":"2022-09-16","current":24.217473,"twenty":14.673898,"median":18.765235,"eighty":25.573003,"marketCap":2730108438},{"date":"2022-09-23","current":23.827942,"twenty":14.673898,"median":18.765235,"eighty":25.52154,"marketCap":2686195356},{"date":"2022-09-30","current":24.359985,"twenty":14.673898,"median":18.765235,"eighty":25.435028,"marketCap":2746174199},{"date":"2022-10-07","current":25.15805,"twenty":14.673898,"median":18.765235,"eighty":25.385744,"marketCap":2836142465},{"date":"2022-10-14","current":25.861107,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":2915400223},{"date":"2022-10-21","current":27.191216,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":3065347332},{"date":"2022-10-28","current":27.020202,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":3046068418},{"date":"2022-11-04","current":23.534301,"twenty":14.673898,"median":18.765235,"eighty":25.345826,"marketCap":2750453769},{"date":"2022-11-11","current":24.409353,"twenty":14.673898,"median":18.765235,"eighty":25.302694,"marketCap":2852721131},{"date":"2022-11-18","current":24.418564,"twenty":14.673898,"median":18.765235,"eighty":25.25389,"marketCap":2853797629},{"date":"2022-11-25","current":24.04091,"twenty":14.673898,"median":18.765235,"eighty":25.245187,"marketCap":2809661189},{"date":"2022-12-02","current":23.00927,"twenty":14.673898,"median":18.765235,"eighty":25.190124,"marketCap":2689093352},{"date":"2022-12-09","current":19.693282,"twenty":14.673898,"median":18.765235,"eighty":25.156355,"marketCap":2301553878},{"date":"2022-12-16","current":18.505053,"twenty":14.673898,"median":18.734208,"eighty":25.11858,"marketCap":2162685566},{"date":"2022-12-23","current":19.020873,"twenty":14.673898,"median":18.727537,"eighty":25.081457,"marketCap":2222969485},{"date":"2022-12-30","current":18.707697,"twenty":14.673898,"median":18.698486,"eighty":25.045958,"marketCap":2186368534},{"date":"2023-01-06","current":19.011662,"twenty":14.673898,"median":18.678417,"eighty":24.974696,"marketCap":2221892986},{"date":"2023-01-13","current":20.669656,"twenty":14.673898,"median":18.678417,"eighty":24.915538,"marketCap":2415662723},{"date":"2023-01-20","current":22.042107,"twenty":14.673898,"median":18.678417,"eighty":24.864493,"marketCap":2576061006},{"date":"2023-01-27","current":21.424965,"twenty":14.673898,"median":18.678417,"eighty":24.824329,"marketCap":2503935604},{"date":"2023-02-03","current":22.401339,"twenty":14.673898,"median":18.678417,"eighty":24.787147,"marketCap":2618044449},{"date":"2023-02-10","current":21.185477,"twenty":14.673898,"median":18.678417,"eighty":24.732601,"marketCap":2475946642},{"date":"2023-02-17","current":20.752556,"twenty":14.673898,"median":18.678417,"eighty":24.674168,"marketCap":2425351210},{"date":"2023-02-24","current":19.628805,"twenty":14.704915,"median":18.698486,"eighty":24.658704,"marketCap":2294018388},{"date":"2023-03-03","current":20.427014,"twenty":14.743485,"median":18.748075,"eighty":24.658704,"marketCap":2071666867},{"date":"2023-03-10","current":22.022874,"twenty":14.846954,"median":18.83403,"eighty":24.658704,"marketCap":2233515841},{"date":"2023-03-17","current":21.95904,"twenty":14.846954,"median":18.881519,"eighty":24.658704,"marketCap":2227041882},{"date":"2023-03-24","current":23.161255,"twenty":14.846954,"median":18.911757,"eighty":24.658704,"marketCap":2348968109},{"date":"2023-03-31","current":23.044225,"twenty":14.880165,"median":18.956878,"eighty":24.656936,"marketCap":2337099184},{"date":"2023-04-06","current":23.269603,"twenty":14.939906,"median":19.012,"eighty":24.656936,"marketCap":2359956610},{"date":"2023-04-14","current":22.558279,"twenty":14.998571,"median":19.051009,"eighty":24.658704,"marketCap":2287815518},{"date":"2023-04-21","current":22.334547,"twenty":14.998571,"median":19.104305,"eighty":24.658704,"marketCap":2265125109},{"date":"2023-04-28","current":22.344563,"twenty":14.998571,"median":19.166026,"eighty":24.658704,"marketCap":2266140860},{"date":"2023-05-05","current":25.797561,"twenty":15.006317,"median":19.199679,"eighty":24.674168,"marketCap":2437869528},{"date":"2023-05-12","current":25.70082,"twenty":15.067256,"median":19.220918,"eighty":24.732601,"marketCap":2428727517},{"date":"2023-05-19","current":25.851306,"twenty":15.164442,"median":19.305872,"eighty":24.787147,"marketCap":2442948422},{"date":"2023-05-26","current":26.356508,"twenty":15.226034,"median":19.370302,"eighty":24.824329,"marketCap":2490690034},{"date":"2023-06-02","current":24.690416,"twenty":15.273706,"median":19.394904,"eighty":24.82815,"marketCap":2333244294},{"date":"2023-06-09","current":25.840557,"twenty":15.369745,"median":19.488201,"eighty":24.87997,"marketCap":2441932643},{"date":"2023-06-16","current":24.926893,"twenty":15.394885,"median":19.593928,"eighty":24.927234,"marketCap":2355591431},{"date":"2023-06-23","current":24.023979,"twenty":15.563594,"median":19.67904,"eighty":24.927405,"marketCap":2270265997},{"date":"2023-06-30","current":23.250052,"twenty":15.628233,"median":19.743196,"eighty":24.927575,"marketCap":2197129912},{"date":"2023-07-07","current":23.615517,"twenty":15.686181,"median":19.772513,"eighty":24.927575,"marketCap":2231666397},{"date":"2023-07-14","current":24.314201,"twenty":15.761523,"median":19.849055,"eighty":24.927746,"marketCap":2297692030},{"date":"2023-07-21","current":25.077379,"twenty":15.821796,"median":19.960736,"eighty":24.935276,"marketCap":2369812337},{"date":"2023-07-28","current":26.904706,"twenty":15.876709,"median":20.074148,"eighty":25.002136,"marketCap":2542494761},{"date":"2023-08-04","current":33.858501,"twenty":15.929368,"median":20.130809,"eighty":25.06021,"marketCap":3203555971},{"date":"2023-08-11","current":33.273239,"twenty":15.97248,"median":20.230235,"eighty":25.077379,"marketCap":3148180804},{"date":"2023-08-18","current":33.067314,"twenty":16.047822,"median":20.286868,"eighty":25.09781,"marketCap":3128696949},{"date":"2023-08-25","current":34.432925,"twenty":16.153301,"median":20.335787,"eighty":25.131471,"marketCap":3257905672},{"date":"2023-09-01","current":35.473392,"twenty":16.199879,"median":20.360084,"eighty":25.165508,"marketCap":3356350414},{"date":"2023-09-08","current":35.928595,"twenty":16.288916,"median":20.424644,"eighty":25.202732,"marketCap":3399419988},{"date":"2023-09-15","current":36.633078,"twenty":16.372908,"median":20.485854,"eighty":25.247633,"marketCap":3466075282},{"date":"2023-09-22","current":34.606336,"twenty":16.402788,"median":20.528058,"eighty":25.271098,"marketCap":3274313129},{"date":"2023-09-29","current":35.755184,"twenty":16.454668,"median":20.647713,"eighty":25.318027,"marketCap":3383012531},{"date":"2023-10-06","current":28.710362,"twenty":16.484805,"median":20.739765,"eighty":25.352329,"marketCap":2716459592},{"date":"2023-10-13","current":29.935077,"twenty":16.545079,"median":20.805107,"eighty":25.396593,"marketCap":2832337257},{"date":"2023-10-20","current":30.346928,"twenty":16.62042,"median":20.91148,"eighty":25.46924,"marketCap":2871304968},{"date":"2023-10-27","current":29.870048,"twenty":16.635578,"median":20.971474,"eighty":25.500078,"marketCap":2826184461},{"date":"2023-11-03","current":28.378566,"twenty":16.744505,"median":21.039532,"eighty":25.568245,"marketCap":2593403665},{"date":"2023-11-10","current":28.097921,"twenty":16.816673,"median":21.093333,"eighty":25.60843,"marketCap":2567756602},{"date":"2023-11-17","current":28.323516,"twenty":16.948321,"median":21.176265,"eighty":25.655139,"marketCap":2588372874},{"date":"2023-11-24","current":28.571672,"twenty":16.9786,"median":21.207187,"eighty":25.701265,"marketCap":2611050772},{"date":"2023-12-01","current":28.729588,"twenty":17.023968,"median":21.222783,"eighty":25.744003,"marketCap":2625482162},{"date":"2023-12-08","current":30.15084,"twenty":17.075645,"median":21.281808,"eighty":25.795392,"marketCap":2755364672},{"date":"2023-12-15","current":33.647571,"twenty":17.145357,"median":21.387263,"eighty":25.809981,"marketCap":3074916879},{"date":"2023-12-22","current":35.711769,"twenty":17.182275,"median":21.514351,"eighty":25.859066,"marketCap":3263555762},{"date":"2023-12-29","current":37.087902,"twenty":17.245845,"median":21.57635,"eighty":25.875763,"marketCap":3389315018},{"date":"2024-01-05","current":28.582951,"twenty":17.249581,"median":21.617351,"eighty":25.902621,"marketCap":2612081586},{"date":"2024-01-12","current":26.451074,"twenty":17.300075,"median":21.662782,"eighty":26.071548,"marketCap":2417257821},{"date":"2024-01-19","current":27.906165,"twenty":17.358343,"median":21.792961,"eighty":26.115814,"marketCap":2550232772},{"date":"2024-01-26","current":25.898365,"twenty":17.391973,"median":21.940702,"eighty":26.170789,"marketCap":2366747956},{"date":"2024-02-02","current":24.398155,"twenty":17.425443,"median":22.062266,"eighty":26.170789,"marketCap":2229649751},{"date":"2024-02-09","current":25.368215,"twenty":17.524077,"median":22.147709,"eighty":26.170789,"marketCap":2318299718},{"date":"2024-02-16","current":23.855618,"twenty":17.589266,"median":22.21893,"eighty":26.191114,"marketCap":2532035310},{"date":"2024-02-23","current":22.42194,"twenty":17.626358,"median":22.234584,"eighty":26.191114,"marketCap":2379864750},{"date":"2024-03-01","current":22.919339,"twenty":17.633519,"median":22.273273,"eighty":26.186954,"marketCap":2432658618},{"date":"2024-03-08","current":22.802304,"twenty":17.633519,"median":22.340405,"eighty":26.186954,"marketCap":2420236531},{"date":"2024-03-15","current":23.085138,"twenty":17.633519,"median":22.41652,"eighty":26.186954,"marketCap":2450256573},{"date":"2024-03-22","current":24.138453,"twenty":17.633519,"median":22.460952,"eighty":26.186954,"marketCap":2562055353},{"date":"2024-03-28","current":24.694368,"twenty":17.690591,"median":22.494795,"eighty":26.186954,"marketCap":2621060264},{"date":"2024-04-05","current":24.43104,"twenty":17.751499,"median":22.557044,"eighty":26.191114,"marketCap":2593110569},{"date":"2024-04-12","current":23.303197,"twenty":17.751499,"median":22.576228,"eighty":26.191114,"marketCap":2473401294},{"date":"2024-04-19","current":22.168364,"twenty":17.751499,"median":22.605072,"eighty":26.191114,"marketCap":2352950181},{"date":"2024-04-26","current":21.728128,"twenty":17.75667,"median":22.602899,"eighty":26.186954,"marketCap":2306223456},{"date":"2024-05-03","current":22.106275,"twenty":17.75667,"median":22.608023,"eighty":26.186954,"marketCap":2609048925},{"date":"2024-05-10","current":23.464761,"twenty":17.774039,"median":22.609769,"eighty":26.186954,"marketCap":2769381540},{"date":"2024-05-17","current":24.293967,"twenty":17.84352,"median":22.678242,"eighty":26.186954,"marketCap":2867246903},{"date":"2024-05-24","current":24.558607,"twenty":17.897853,"median":22.753585,"eighty":26.186954,"marketCap":2898480529},{"date":"2024-05-31","current":27.531399,"twenty":17.929134,"median":22.805275,"eighty":26.264877,"marketCap":3249338266},{"date":"2024-06-07","current":30.415976,"twenty":17.97088,"median":22.828928,"eighty":26.281877,"marketCap":3589784794},{"date":"2024-06-14","current":27.796039,"twenty":18.005093,"median":22.893398,"eighty":26.32196,"marketCap":3280571892},{"date":"2024-06-21","current":25.934736,"twenty":18.025346,"median":22.970196,"eighty":26.326142,"marketCap":3060895387},{"date":"2024-06-28","current":28.281212,"twenty":18.058813,"median":23.010789,"eighty":26.361392,"marketCap":3337833541},{"date":"2024-07-05","current":26.905084,"twenty":18.08407,"median":23.045023,"eighty":26.401346,"marketCap":3175418684},{"date":"2024-07-12","current":27.496113,"twenty":18.125253,"median":23.112931,"eighty":26.435971,"marketCap":3245173782},{"date":"2024-07-15","current":27.787218,"twenty":18.151583,"median":23.125276,"eighty":26.439168,"marketCap":3279530772},{"date":"2024-08-02","current":31.468089,"twenty":18.227878,"median":23.207056,"eighty":26.472425,"marketCap":3964444273},{"date":"2024-08-09","current":28.258245,"twenty":18.289588,"median":23.250052,"eighty":26.573962,"marketCap":3560058418},{"date":"2024-08-16","current":28.979837,"twenty":18.299654,"median":23.308355,"eighty":26.638271,"marketCap":3650966866},{"date":"2024-08-23","current":28.432422,"twenty":18.299654,"median":23.412836,"eighty":26.737384,"marketCap":3582001837},{"date":"2024-08-30","current":29.145721,"twenty":18.420312,"median":23.48289,"eighty":26.875577,"marketCap":3671865360},{"date":"2024-09-06","current":28.283127,"twenty":18.479546,"median":23.50276,"eighty":26.907206,"marketCap":3563193192},{"date":"2024-09-13","current":29.618489,"twenty":18.489602,"median":23.553278,"eighty":26.969813,"marketCap":3731426067},{"date":"2024-09-20","current":33.939752,"twenty":18.489602,"median":23.628594,"eighty":27.012802,"marketCap":4275831831},{"date":"2024-09-27","current":35.897177,"twenty":18.489602,"median":23.704432,"eighty":27.065252,"marketCap":4522434058},{"date":"2024-10-04","current":37.356951,"twenty":18.489602,"median":23.766003,"eighty":27.198317,"marketCap":4706340803},{"date":"2024-10-11","current":37.531129,"twenty":18.489602,"median":23.79825,"eighty":27.269122,"marketCap":4728284222},{"date":"2024-10-18","current":39.12361,"twenty":18.489602,"median":23.827222,"eighty":27.390639,"marketCap":4928909762},{"date":"2024-10-25","current":39.181669,"twenty":18.489602,"median":23.839773,"eighty":27.531768,"marketCap":4936224235},{"date":"2024-10-31","current":34.548872,"twenty":18.489602,"median":23.855618,"eighty":27.607335,"marketCap":4899651871},{"date":"2024-11-08","current":40.116839,"twenty":18.488035,"median":23.944067,"eighty":27.690634,"marketCap":5689289939},{"date":"2024-11-15","current":40.478851,"twenty":18.488035,"median":24.018628,"eighty":27.792827,"marketCap":5740629756},{"date":"2024-11-22","current":41.313695,"twenty":18.501556,"median":24.046375,"eighty":27.825976,"marketCap":5859025661},{"date":"2024-11-29","current":42.613983,"twenty":18.57617,"median":24.098183,"eighty":27.94226,"marketCap":6043429902},{"date":"2024-12-06","current":43.899495,"twenty":18.605886,"median":24.135934,"eighty":28.081714,"marketCap":6225738640},{"date":"2024-12-13","current":41.612909,"twenty":18.704013,"median":24.157567,"eighty":28.205158,"marketCap":5901459591},{"date":"2024-12-20","current":37.789619,"twenty":18.861587,"median":24.179738,"eighty":28.267432,"marketCap":5359248257},{"date":"2024-12-27","current":39.621843,"twenty":18.901855,"median":24.222326,"eighty":28.295017,"marketCap":5619090597},{"date":"2025-01-03","current":36.917836,"twenty":18.962014,"median":24.246775,"eighty":28.334601,"marketCap":5235613595},{"date":"2025-01-10","current":38.188571,"twenty":19.031446,"median":24.276325,"eighty":28.377038,"marketCap":5415826831},{"date":"2025-01-17","current":40.220271,"twenty":19.099543,"median":24.296939,"eighty":28.43093,"marketCap":5703958458},{"date":"2025-01-24","current":46.019851,"twenty":19.160732,"median":24.33572,"eighty":28.461514,"marketCap":6526443283},{"date":"2025-01-31","current":51.642119,"twenty":19.203927,"median":24.359985,"eighty":28.529757,"marketCap":7323782076},{"date":"2025-02-07","current":50.267951,"twenty":19.239158,"median":24.395104,"eighty":28.578439,"marketCap":7128900321},{"date":"2025-02-14","current":54.383067,"twenty":19.337603,"median":24.413752,"eighty":28.61904,"marketCap":7712497834},{"date":"2025-02-21","current":48.088491,"twenty":19.396463,"median":24.43104,"eighty":28.65241,"marketCap":6819813667},{"date":"2025-02-28","current":44.716558,"twenty":19.542449,"median":24.466366,"eighty":28.709029,"marketCap":6314380405},{"date":"2025-03-07","current":40.56991,"twenty":19.695185,"median":24.537351,"eighty":28.774142,"marketCap":5728836357},{"date":"2025-03-14","current":40.980839,"twenty":19.748215,"median":24.572457,"eighty":28.848313,"marketCap":5786863245},{"date":"2025-03-21","current":43.028013,"twenty":19.828981,"median":24.656668,"eighty":28.895923,"marketCap":6075942648},{"date":"2025-03-28","current":42.348112,"twenty":20.044795,"median":24.686713,"eighty":29.033234,"marketCap":5979934525},{"date":"2025-04-04","current":59.300805,"twenty":20.122482,"median":24.719586,"eighty":29.225898,"marketCap":8373807397},{"date":"2025-04-11","current":50.604051,"twenty":20.229693,"median":24.759018,"eighty":29.315721,"marketCap":7145747449},{"date":"2025-04-17","current":48.265491,"twenty":20.286086,"median":24.779141,"eighty":29.454515,"marketCap":6815521707}],"updateTime":1745262122160}}}